Key Documents
Curriculum Vitae available Online
Laurence Katznelson
- Associate Professor - Med Center Line, Medicine - Endocrinology/Gerontology/Metab
- Associate Professor - Med Center Line, Neurosurgery
- Member, Cancer Center
Contact Information
- Clinical Offices
Stanford Comprehensive Cancer Center 875 Blake Wilbur Dr MC 5826 Stanford, CA 94305 Telephone Work (650) 736-2062 Fax (650) 724-9214
- Academic Offices
Personal Information Email LKatznelson@stanford.eduAdministrative Contact Kimm Angel Administrative Assistant Email kangel@stanford.edu Tel Work 650-721-1020Not for medical emergencies or patient use
Clinical Focus
- Cancer > Neuro Oncology
- Endocrine
- Endocrine - Endocrinology
- Endocrinology
- Multiple Endocrine Neoplasias
- Multiple Endocrine Neoplasias - Endocrinology
- Neuroendocrine
- Neuroendocrine - Endocrinology
- Neuroendocrine - Medical Oncology
- Parathyroid Disease
- Parathyroid Disease - Endocrinology
- Pituitary Adenomas
- Pituitary Adenomas - Endocrinology
- acromegaly
- Cushing's
- Cushing's Syndrome
- Cushing Disease
- Prolactinoma
- Adrenal Gland Neoplasms
- Adrenal Cortex Diseases
- Growth Hormone-Secreting Pituitary Adenoma
- Growth Hormone Deficiency Dwarfism
- Hyperprolactinemia
- Hypopituitarism
- Endocrinology and Metabolism
Administrative Appointments
- Chair, Special Programs Committee, Endocrine Society , (2008– present )
- Director, Endocrinology Fellowship Training Program, Stanford , (2005– present )
- Medical Director, Stanford Pituitary Center , (2004– present )
Honors and Awards
- Best Doctors in America, Best Doctors (2005-)
Professional Education
- Board Certification: Endocrinology and Metabolism, American Board of Internal Medicine (1991)
- Board Certification, Board of Internal Medicine Endocrinology and Metabolism (1991)
- Massachusetts General Hospital (1992) MA
- Board Certification: Internal Medicine, American Board of Internal Medicine (1988)
- Hospital of the University of Pennsylvania (1989) PA
- Hospital of the University of Pennsylvania (1986) PA
- UCLA School of Medicine (1985) CA
- Endocrinology, Mass. General Hosp, Boston Endocrinology and Metabolism (1992)
- BS, U.C., Berkeley Genetics (1981)
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.
- Consulting: Novo nordisk, Tercica
Research Interests
My clinical and research interests in neuroendocrinology include the following programs:
1. Investigations into the effects of brain injury on pituitary function, with emphasis on the impact of hypopituitarism on rehabilitation
2. Research on the effects of neuroendocrine factors, including growth hormone and glucocorticoids, on neurocognitive function
3. Investigations into novel therapeutic modalities for acromegaly and hypopituitarism
4. Research into the effects of anabolic hormones such as gonadal steroids and growth hormone on body composition
Clinical Trials
- A multicenter, randomized, blinded study to assess safety and efficacy of pasireotide LAR vs. octreotide LAR in patients with active acromegaly Recruiting
- A randomized, double-blind study to assess the safety and efficacy of different dose levels of Pasireotide (SOM230) s.c. over a 6 month treatment period in patients with de novo, persistent or recurrent Cushing's disease Recruiting
- Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults Recruiting
- Efficacy and Safety Study of CORLUX (mifepristone) in the Treatment of Endogenous Cushing’s Syndrome Recruiting
- PHASE III, OPEN-LABEL, MULTICENTER INTERNATIONAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AN OCTREOTIDE IMPLANT VERSUS SANDOSTATIN LAR® DEPOT IN PATIENTS WITH ACROMEGALY Recruiting
- SAFETY AND BIOLOGICAL ACTIVITY OF A NEW PROLONGED RELEASE FORMULATION OF OCTREOTIDE ACETATE, C2L-OCT-01 PR, ADMINISTERED INTRAMUSCULARLY EVERY 4, 5 OR 6 WEEKS IN ACROMEGALIC PATIENTS Recruiting
- An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Completed
- XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors Completed
- XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema No longer recruiting
Publications
- J Clin Neurosci. 2009; (8): 985-93
- Pituitary. 2009; (4): 347-51
- Pituitary. 2009; (2): 136-42
- Endocr Relat Cancer. 2009; (3): 1045-55
- Ann Surg Oncol. 2009; (4): 962-8
- Endocr Pract. 2009; 1-22
- Brain Inj. 2009; (7): 639-48
- J Clin Endocrinol Metab. 2008; (2): 358-62
- J Hypertens. 2008; (2): 368-73
- Expert Opin Pharmacother. 2008; (13): 2273-80
- Neurosurgery. 2008; (2): 266-70; discussion 270-1
- J Neurosurg. 2008; (5): 889-92
- Nat Clin Pract Endocrinol Metab. 2007; (7): 514-5
- Pituitary. 2007; (2): 205-11
- Curr Opin Endocrinol Diabetes Obes. 2007; (4): 311-6
- Neurosurg Focus. 2007; (3): E2
- Neurosurg Focus. 2007; (3): E11
- Pituitary. 2007; (1): 19-25
- Endocr Pract. 2006 Nov-Dec; (6): 660-3
- Eur J Endocrinol. 2006; (6): 867-75
- Nat Clin Pract Endocrinol Metab. 2006; (2): 109-17; quiz following 117
- Growth Horm IGF Res. 2005; S31-5
- J Clin Endocrinol Metab. 2005; (8): 4465-73
- J Clin Endocrinol Metab. 2004; (8): 3752-63
- J Clin Endocrinol Metab. 2003; (11): 5468-72
- J Clin Endocrinol Metab. 2002; (4): 1692-9
- Lancet. 2001; (9295): 1754-9
- Int J Radiat Oncol Biol Phys. 2001; (4): 1079-92
- Clin Endocrinol (Oxf). 2001; (2): 183-8
- J Clin Endocrinol Metab. 2001; (7): 2976-81
- N Engl J Med. 2000; (16): 1171-7
- J Clin Endocrinol Metab. 1998; (5): 1619-23